Companies sponsors |
Eli Lilly (abemaciclib) |
Others |
Department of Health and Social Care |
|
NHS England |
|
NHS Vale of York CCG |
|
NHS Hambleton, Richmondshire and Whitby CCG |
|
Welsh Government |
Patient carer groups |
Black Health Agency |
|
Breast Cancer Now |
|
Breast Cancer Haven |
|
Breast Cancer UK |
|
Cancer Black Care |
|
Cancer Equality |
|
Helen Rollason Cancer Charity |
|
Independent Cancer Patients Voice |
|
Macmillan Cancer Support |
|
Maggie’s Centres |
|
Marie Curie |
|
South Asian Health Foundation |
|
Specialised Healthcare Alliance |
|
Tenovus Cancer Care |
Professional groups |
Association of Anaesthetists |
|
Association of Breast Surgery |
|
Association of Cancer Physicians |
|
Association of Surgeons of Great Britain & Ireland |
|
British Association of Surgical Oncology |
|
British Geriatrics Society |
|
British Institute of Radiology |
|
British Psychosocial Oncology Society |
|
Cancer Research UK |
|
Royal College of Anaesthetists |
|
Royal College of General Practitioners |
|
Royal College of Nursing |
|
Royal College of Pathologists |
|
Royal College of Physicians |
|
Royal College of Radiologists |
|
Royal College of Surgeons |
|
Royal Pharmaceutical Society |
|
Royal Society of Medicine |
|
Society and College of Radiographers |
|
UK Breast Cancer Group |
|
UK Clinical Pharmacy Association |
|
UK Oncology Nursing Society |
Associated public health groups |
Public Health England |
|
Public Health Wales |
Comparator companies |
Accord Healthcare Limited (anastrozole, exemestane, letrozole) |
|
Aurobindo Pharma (tamoxifen) |
|
AstraZeneca UK Limited (anastrozole) |
|
Cipla EU Ltd (letrozole) |
|
Dr. Reddy’s Laboratories (UK) Ltd (letrozole) |
|
Glenmark Pharmaceuticals Europe Ltd (exemestane, letrozole) |
|
Mylan (anastrozole, exemestane, tamoxifen) |
|
Novartis Pharmaceuticals UK Ltd (letrozole) |
|
Pfizer Limited (exemestane) |
|
Ranbaxy (UK) Limited a Sun Pharmaceutical Company (anastrozole, letrozole) |
|
Rosemont Pharmaceuticals Limited (tamoxifen) |
|
Sandoz Limited (anastrozole) |
|
Tillomed Laboratories Ltd (tamoxifen) |
|
Wockhardt UK Ltd (anastrozole, tamoxifen) |
|
Zentiva (exemestane) |
General commentators |
All Wales Therapeutics and Toxicology Centre |
|
Allied Health Professionals Federation |
|
Board of Community Health Councils in Wales |
|
British National Formulary |
|
Care Quality Commission |
|
Department of Health, Social Services and Public Safety for Northern Ireland |
|
Healthcare Improvement Scotland |
|
Medicines and Healthcare products Regulatory Agency |
|
National Association for Primary Care |
|
National Pharmacy Association |
|
NHS Alliance |
|
NHS Commercial Medicines Unit |
|
NHS Confederation |
|
Scottish Medicines Consortium |
|
Welsh Health Specialised Services Committee |
Relevant research groups |
Against Breast Cancer |
|
Breast Cancer Hope |
|
Breast Cancer Research Trust |
|
Cochrane Breast Cancer Group |
|
Genomics England |
|
Institute of Cancer Research |
|
MRC Clinical Trials Unit |
|
National Cancer Research Institute |
|
National Cancer Research Network |
|
National Institute for Health Research |
|
Pro-Cancer Research Fund |